RBD-5089

N/A

Report date: 2023/09/06 17:58:44
NME

Base Information

Drug NameRBD-5089
Drug Alias NameRBD-5089RBD5089
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interference
TargetsUpdating
Therapy Area/IndicationsHepatitis D
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSuzhou Ribo Life Science Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesSuzhou Ribo Life Science Co Ltd
Inactive CompaniesN/A
Active IndicationsHepatitis D
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A